Clinical trial
Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea
NCT00250458 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00250458 |
|---|---|
| Title | Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Elimination of Migraine-Associated Nausea in Migraine Patients Treated With Rizatriptan Orally Disintegrating Tablet (ODT) |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | Comparator: Rizatriptan, Comparator: Placebo |
| Enrollment | 346 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Nov 8, 2005 |
| Last update posted | Feb 3, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: